Skip to main content
Log in

Pharmacokinetics and bioavailability of viqualine a new antidepressant

  • Original Papers
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

A high performance liquid chromatographic assay was developed for plasma and urine levels measurement of viqualine. The assay was used to study the disposition of 25 mg intravenous and oral single doses in five healthy subjects. Two exponential terms were required to describe the disposition of the drug after intravenous and oral administration. The bioavailability of oral viqualine averaged 80%. The mean apparent half-life was 12.1 ± 1.9 and 11.9 ± 1.4 h (mean ± s.e.m., n = 5) after 25 mg I.V. and oral dose respectively. The apparent volume of distribution (Vdss) were 1578 ± 132 1 (after I.V. administration) and 1572 ± 201 1 (after oral administration). The body and renal clearances were respectively 1.56 ± 0.31 1.h−1. kg−1 and 1.57 ± 0.31 1.h−1. kg−1, after 25 mg bolus I.V.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Coppen A., Prange A. Jr., Whybrow P.C. and Noguera R. (1972): Abnormalities of indoleamines in affective disorders. Arch. gen. Psychiat.,26, 474–478.

    CAS  PubMed  Google Scholar 

  2. Le Fur G. and Uzan A. (1977): Effects of 4-(3-indoylalkyl) piperidine derivates on uptake and release of nor adrenaline, dopamine and 5-hydroxytryptamine in rat brain synaptosomes, rat heart and human blood platets. Biochem. Pharmacol.,26, 497–503.

    Article  PubMed  Google Scholar 

  3. Le Fur G., Imbault F., Mitrani N., Marquis S., Renault C., Dubroeucq M.C., Gueremy C. and Uzan A. (1984): 5-hydroxytryptamine releasing properties of two epimer quinoline derivates. Neuropharmacol.,23, 169–173.

    Article  Google Scholar 

  4. Van Praag H.M. and Korf J. (1974): Serotonin metabolism in depression: clinical application of the probenicid test. Int. Pharmacopsychiat.,9, 35–51.

    Google Scholar 

  5. Fourtillan J.B., Bouquet S., Lefebvre M.A. and Girault J: Determination of viqualine in human plasma and urine by CLHP. J. of Liq. in press.

  6. Gomeni C. and Gomeni R. (1978): Interactive graphic package for pharmacokinetic analysis computers. Biomedical Research.,2, 345–361.

    Google Scholar 

  7. Kruger R. and Thiemer E. (1977): Kinetic aspects of absorption, distribution and elimination of drugs, Van Rosum J.M. (ed). Berlin Heidelberg, New York, 62–123.

  8. Hrdina P.D., Rovci V., Henry J.F., Hervy M.P., Gomeni R., Forette F. and Morselli P.L. (1980): Comparaison of single dose pharmacokinetics of imipramine and maprotiline in ederly. Psychopharmacol.,70, 29–34.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fourtillan, J.B., Bouquet, S., Girault, J. et al. Pharmacokinetics and bioavailability of viqualine a new antidepressant. European Journal of Drug Metabolism and Pharmacokinetics 10, 3–10 (1985). https://doi.org/10.1007/BF03189690

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189690

Key-words

Navigation